APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimicrobial Effectiveness Testing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Antimicrobial Effectiveness Testing Service Market Outlook and Growth Opportunities 2026

11 April 2026Not stated

Choose your research edition.

Industry ResearchAntimicrobial Effectiveness Testing Service Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimicrobial Effectiveness Testing Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Antimicrobial Effectiveness Testing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimicrobial Effectiveness Testing Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Antimicrobial Effectiveness Testing Service Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Antimicrobial Effectiveness Testing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Antimicrobial Effectiveness Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antimicrobial Effectiveness Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antimicrobial Effectiveness Testing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Antimicrobial Effectiveness Testing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Antimicrobial Effectiveness Testing Service market include Intertek, Eurofins, Almac, Steris, Aemtek, Q Laboratories, Wickham Micro, Nelson Labs and MycoScience, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Antimicrobial Effectiveness Testing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antimicrobial Effectiveness Testing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antimicrobial Effectiveness Testing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Antimicrobial Effectiveness Testing Service market.

Antimicrobial Effectiveness Testing Service Segment by Company

Intertek

Eurofins

Almac

Steris

Aemtek

Q Laboratories

Wickham Micro

Nelson Labs

MycoScience

Reading Scientific Services

MSL Solution Providers

Consumer Product Testing Company

QACS

Microchem Laboratory

BioScreen

Lucideon

Microbac

Pace Life Sciences

Neopharm

Pacific BioLabs

BA Sciences

SGS S.A.

Antimicrobial Effectiveness Testing Service Segment by Type

USP Standard Testing

EP Standard Testing

Antimicrobial Effectiveness Testing Service Segment by Application

Pharmaceutical

Cosmetic

Cleaning Supplies

Others

Antimicrobial Effectiveness Testing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Antimicrobial Effectiveness Testing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Antimicrobial Effectiveness Testing Service key companies, revenue, market share, and recent developments.

3. To split the Antimicrobial Effectiveness Testing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Antimicrobial Effectiveness Testing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Antimicrobial Effectiveness Testing Service significant trends, drivers, influence factors in global and regions.

6. To analyze Antimicrobial Effectiveness Testing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimicrobial Effectiveness Testing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimicrobial Effectiveness Testing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimicrobial Effectiveness Testing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Antimicrobial Effectiveness Testing Service industry.

Chapter 3: Detailed analysis of Antimicrobial Effectiveness Testing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Antimicrobial Effectiveness Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Antimicrobial Effectiveness Testing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Antimicrobial Effectiveness Testing Service Industry Trends Table 2. Antimicrobial Effectiveness Testing Service Industry Drivers Table 3. Antimicrobial Effectiveness Testing Service Industry Opportunities and Challenges Table 4. Antimicrobial Effectiveness Testing Service Industry Restraints Table 5. Global Antimicrobial Effectiveness Testing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Antimicrobial Effectiveness Testing Service Revenue Share by Company (2021-2026) Table 7. Global Antimicrobial Effectiveness Testing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Antimicrobial Effectiveness Testing Service Key Company Manufacturing Base & Headquarters Table 9. Global Antimicrobial Effectiveness Testing Service Company, Product Type & Application Table 10. Global Antimicrobial Effectiveness Testing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Antimicrobial Effectiveness Testing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of USP Standard Testing Table 15. Significant Companies of EP Standard Testing Table 16. Global Antimicrobial Effectiveness Testing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Antimicrobial Effectiveness Testing Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Antimicrobial Effectiveness Testing Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Type (2021-2026) Table 20. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Table 22. Significant Companies of Cosmetic Table 23. Significant Companies of Cleaning Supplies Table 24. Significant Companies of Others Table 25. Global Antimicrobial Effectiveness Testing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Antimicrobial Effectiveness Testing Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Antimicrobial Effectiveness Testing Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Application (2021-2026) Table 29. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Application (2027-2032) Table 30. Global Antimicrobial Effectiveness Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Antimicrobial Effectiveness Testing Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Region (2021-2026) Table 33. Global Antimicrobial Effectiveness Testing Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Region (2027-2032) Table 35. Global Antimicrobial Effectiveness Testing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Antimicrobial Effectiveness Testing Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Antimicrobial Effectiveness Testing Service Sales Value Market Share by Country (2021-2026) Table 38. Global Antimicrobial Effectiveness Testing Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Antimicrobial Effectiveness Testing Service Sales Value Market Share by Country (2027-2032) Table 40. Intertek Company Information Table 41. Intertek Business Overview Table 42. Intertek Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Intertek Antimicrobial Effectiveness Testing Service Product Portfolio Table 44. Intertek Recent Development Table 45. Eurofins Company Information Table 46. Eurofins Business Overview Table 47. Eurofins Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Eurofins Antimicrobial Effectiveness Testing Service Product Portfolio Table 49. Eurofins Recent Development Table 50. Almac Company Information Table 51. Almac Business Overview Table 52. Almac Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Almac Antimicrobial Effectiveness Testing Service Product Portfolio Table 54. Almac Recent Development Table 55. Steris Company Information Table 56. Steris Business Overview Table 57. Steris Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Steris Antimicrobial Effectiveness Testing Service Product Portfolio Table 59. Steris Recent Development Table 60. Aemtek Company Information Table 61. Aemtek Business Overview Table 62. Aemtek Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Aemtek Antimicrobial Effectiveness Testing Service Product Portfolio Table 64. Aemtek Recent Development Table 65. Q Laboratories Company Information Table 66. Q Laboratories Business Overview Table 67. Q Laboratories Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Q Laboratories Antimicrobial Effectiveness Testing Service Product Portfolio Table 69. Q Laboratories Recent Development Table 70. Wickham Micro Company Information Table 71. Wickham Micro Business Overview Table 72. Wickham Micro Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Wickham Micro Antimicrobial Effectiveness Testing Service Product Portfolio Table 74. Wickham Micro Recent Development Table 75. Nelson Labs Company Information Table 76. Nelson Labs Business Overview Table 77. Nelson Labs Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Nelson Labs Antimicrobial Effectiveness Testing Service Product Portfolio Table 79. Nelson Labs Recent Development Table 80. MycoScience Company Information Table 81. MycoScience Business Overview Table 82. MycoScience Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. MycoScience Antimicrobial Effectiveness Testing Service Product Portfolio Table 84. MycoScience Recent Development Table 85. Reading Scientific Services Company Information Table 86. Reading Scientific Services Business Overview Table 87. Reading Scientific Services Antimicrobial Effectiveness Testing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Reading Scientific Services Antimicrobial Effectiveness Testing Service Product Portfolio Table 89. Reading Scientific Services Recent Development Table 90. MSL Solution Providers Company Information Table 91. MSL Solution Providers Business Overview Table 92. MSL Solution Providers Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. MSL Solution Providers Antimicrobial Effectiveness Testing Service Product Portfolio Table 94. MSL Solution Providers Recent Development Table 95. Consumer Product Testing Company Company Information Table 96. Consumer Product Testing Company Business Overview Table 97. Consumer Product Testing Company Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Consumer Product Testing Company Antimicrobial Effectiveness Testing Service Product Portfolio Table 99. Consumer Product Testing Company Recent Development Table 100. QACS Company Information Table 101. QACS Business Overview Table 102. QACS Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. QACS Antimicrobial Effectiveness Testing Service Product Portfolio Table 104. QACS Recent Development Table 105. Microchem Laboratory Company Information Table 106. Microchem Laboratory Business Overview Table 107. Microchem Laboratory Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Microchem Laboratory Antimicrobial Effectiveness Testing Service Product Portfolio Table 109. Microchem Laboratory Recent Development Table 110. BioScreen Company Information Table 111. BioScreen Business Overview Table 112. BioScreen Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. BioScreen Antimicrobial Effectiveness Testing Service Product Portfolio Table 114. BioScreen Recent Development Table 115. Lucideon Company Information Table 116. Lucideon Business Overview Table 117. Lucideon Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Lucideon Antimicrobial Effectiveness Testing Service Product Portfolio Table 119. Lucideon Recent Development Table 120. Microbac Company Information Table 121. Microbac Business Overview Table 122. Microbac Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Microbac Antimicrobial Effectiveness Testing Service Product Portfolio Table 124. Microbac Recent Development Table 125. Pace Life Sciences Company Information Table 126. Pace Life Sciences Business Overview Table 127. Pace Life Sciences Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Pace Life Sciences Antimicrobial Effectiveness Testing Service Product Portfolio Table 129. Pace Life Sciences Recent Development Table 130. Neopharm Company Information Table 131. Neopharm Business Overview Table 132. Neopharm Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. Neopharm Antimicrobial Effectiveness Testing Service Product Portfolio Table 134. Neopharm Recent Development Table 135. Pacific BioLabs Company Information Table 136. Pacific BioLabs Business Overview Table 137. Pacific BioLabs Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Pacific BioLabs Antimicrobial Effectiveness Testing Service Product Portfolio Table 139. Pacific BioLabs Recent Development Table 140. BA Sciences Company Information Table 141. BA Sciences Business Overview Table 142. BA Sciences Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. BA Sciences Antimicrobial Effectiveness Testing Service Product Portfolio Table 144. BA Sciences Recent Development Table 145. SGS S.A. Company Information Table 146. SGS S.A. Business Overview Table 147. SGS S.A. Antimicrobial Effectiveness Testing Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 148. SGS S.A. Antimicrobial Effectiveness Testing Service Product Portfolio Table 149. SGS S.A. Recent Development Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Antimicrobial Effectiveness Testing Service Product Image Figure 2. Global Antimicrobial Effectiveness Testing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimicrobial Effectiveness Testing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Antimicrobial Effectiveness Testing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. USP Standard Testing Image Figure 8. EP Standard Testing Image Figure 9. Global Antimicrobial Effectiveness Testing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Antimicrobial Effectiveness Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Image Figure 13. Cosmetic Image Figure 14. Cleaning Supplies Image Figure 15. Others Image Figure 16. Global Antimicrobial Effectiveness Testing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Antimicrobial Effectiveness Testing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Application (2021-2032) Figure 19. Global Antimicrobial Effectiveness Testing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Antimicrobial Effectiveness Testing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Antimicrobial Effectiveness Testing Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Antimicrobial Effectiveness Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Antimicrobial Effectiveness Testing Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Antimicrobial Effectiveness Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Antimicrobial Effectiveness Testing Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Antimicrobial Effectiveness Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Antimicrobial Effectiveness Testing Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Antimicrobial Effectiveness Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Antimicrobial Effectiveness Testing Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Antimicrobial Effectiveness Testing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • USP Standard Testing
  • EP Standard Testing
Applications
  • Pharmaceutical
  • Cosmetic
  • Cleaning Supplies
  • Others
Companies covered
  • Intertek
  • Eurofins
  • Almac
  • Steris
  • Aemtek
  • Q Laboratories
  • Wickham Micro
  • Nelson Labs
  • MycoScience
  • Reading Scientific Services
  • MSL Solution Providers
  • Consumer Product Testing Company
  • QACS
  • Microchem Laboratory
  • BioScreen
  • Lucideon
  • Microbac
  • Pace Life Sciences
  • Neopharm
  • Pacific BioLabs
  • BA Sciences
  • SGS S.A.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antimicrobial Effectiveness Testing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antimicrobial Effectiveness Testing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Antimicrobial Effectiveness Testing Service Market Dynamics
  1. 2.1 Antimicrobial Effectiveness Testing Service Industry Trends
  2. 2.2 Antimicrobial Effectiveness Testing Service Industry Drivers
  3. 2.3 Antimicrobial Effectiveness Testing Service Industry Opportunities and Challenges
  4. 2.4 Antimicrobial Effectiveness Testing Service Industry Restraints
3 Antimicrobial Effectiveness Testing Service Market by Company
  1. 3.1 Global Antimicrobial Effectiveness Testing Service Company Revenue Ranking in 2025
  2. 3.2 Global Antimicrobial Effectiveness Testing Service Revenue by Company (2021-2026)
  3. 3.3 Global Antimicrobial Effectiveness Testing Service Company Ranking (2024-2026)
  4. 3.4 Global Antimicrobial Effectiveness Testing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Antimicrobial Effectiveness Testing Service Company Product Type and Application
  6. 3.6 Global Antimicrobial Effectiveness Testing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Antimicrobial Effectiveness Testing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Antimicrobial Effectiveness Testing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Antimicrobial Effectiveness Testing Service Market by Type
  1. 4.1 Antimicrobial Effectiveness Testing Service Type Introduction
  2. 4.1.1 USP Standard Testing
  3. 4.1.2 EP Standard Testing
  4. 4.2 Global Antimicrobial Effectiveness Testing Service Sales Value by Type
  5. 4.2.1 Global Antimicrobial Effectiveness Testing Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Antimicrobial Effectiveness Testing Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Antimicrobial Effectiveness Testing Service Sales Value Share by Type (2021-2032)
5 Antimicrobial Effectiveness Testing Service Market by Application
  1. 5.1 Antimicrobial Effectiveness Testing Service Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Cosmetic
  4. 5.1.3 Cleaning Supplies
  5. 5.1.4 Others
  6. 5.2 Global Antimicrobial Effectiveness Testing Service Sales Value by Application
  7. 5.2.1 Global Antimicrobial Effectiveness Testing Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antimicrobial Effectiveness Testing Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Antimicrobial Effectiveness Testing Service Sales Value Share by Application (2021-2032)
6 Antimicrobial Effectiveness Testing Service Regional Value Analysis
  1. 6.1 Global Antimicrobial Effectiveness Testing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antimicrobial Effectiveness Testing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Antimicrobial Effectiveness Testing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Antimicrobial Effectiveness Testing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antimicrobial Effectiveness Testing Service Sales Value (2021-2032)
  7. 6.3.2 North America Antimicrobial Effectiveness Testing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Antimicrobial Effectiveness Testing Service Sales Value (2021-2032)
  10. 6.4.2 Europe Antimicrobial Effectiveness Testing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Antimicrobial Effectiveness Testing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Antimicrobial Effectiveness Testing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Antimicrobial Effectiveness Testing Service Sales Value (2021-2032)
  16. 6.6.2 South America Antimicrobial Effectiveness Testing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Antimicrobial Effectiveness Testing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Antimicrobial Effectiveness Testing Service Sales Value Share by Country, 2025 VS 2032
7 Antimicrobial Effectiveness Testing Service Country-level Value Analysis
  1. 7.1 Global Antimicrobial Effectiveness Testing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Antimicrobial Effectiveness Testing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Antimicrobial Effectiveness Testing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Antimicrobial Effectiveness Testing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Antimicrobial Effectiveness Testing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Antimicrobial Effectiveness Testing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Antimicrobial Effectiveness Testing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Intertek
  2. 8.1.1 Intertek Company Information
  3. 8.1.2 Intertek Business Overview
  4. 8.1.3 Intertek Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Intertek Antimicrobial Effectiveness Testing Service Product Portfolio
  6. 8.1.5 Intertek Recent Developments
  7. 8.2 Eurofins
  8. 8.2.1 Eurofins Company Information
  9. 8.2.2 Eurofins Business Overview
  10. 8.2.3 Eurofins Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Antimicrobial Effectiveness Testing Service Product Portfolio
  12. 8.2.5 Eurofins Recent Developments
  13. 8.3 Almac
  14. 8.3.1 Almac Company Information
  15. 8.3.2 Almac Business Overview
  16. 8.3.3 Almac Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Almac Antimicrobial Effectiveness Testing Service Product Portfolio
  18. 8.3.5 Almac Recent Developments
  19. 8.4 Steris
  20. 8.4.1 Steris Company Information
  21. 8.4.2 Steris Business Overview
  22. 8.4.3 Steris Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Steris Antimicrobial Effectiveness Testing Service Product Portfolio
  24. 8.4.5 Steris Recent Developments
  25. 8.5 Aemtek
  26. 8.5.1 Aemtek Company Information
  27. 8.5.2 Aemtek Business Overview
  28. 8.5.3 Aemtek Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Aemtek Antimicrobial Effectiveness Testing Service Product Portfolio
  30. 8.5.5 Aemtek Recent Developments
  31. 8.6 Q Laboratories
  32. 8.6.1 Q Laboratories Company Information
  33. 8.6.2 Q Laboratories Business Overview
  34. 8.6.3 Q Laboratories Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Q Laboratories Antimicrobial Effectiveness Testing Service Product Portfolio
  36. 8.6.5 Q Laboratories Recent Developments
  37. 8.7 Wickham Micro
  38. 8.7.1 Wickham Micro Company Information
  39. 8.7.2 Wickham Micro Business Overview
  40. 8.7.3 Wickham Micro Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Wickham Micro Antimicrobial Effectiveness Testing Service Product Portfolio
  42. 8.7.5 Wickham Micro Recent Developments
  43. 8.8 Nelson Labs
  44. 8.8.1 Nelson Labs Company Information
  45. 8.8.2 Nelson Labs Business Overview
  46. 8.8.3 Nelson Labs Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nelson Labs Antimicrobial Effectiveness Testing Service Product Portfolio
  48. 8.8.5 Nelson Labs Recent Developments
  49. 8.9 MycoScience
  50. 8.9.1 MycoScience Company Information
  51. 8.9.2 MycoScience Business Overview
  52. 8.9.3 MycoScience Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MycoScience Antimicrobial Effectiveness Testing Service Product Portfolio
  54. 8.9.5 MycoScience Recent Developments
  55. 8.10 Reading Scientific Services
  56. 8.10.1 Reading Scientific Services Company Information
  57. 8.10.2 Reading Scientific Services Business Overview
  58. 8.10.3 Reading Scientific Services Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Reading Scientific Services Antimicrobial Effectiveness Testing Service Product Portfolio
  60. 8.10.5 Reading Scientific Services Recent Developments
  61. 8.11 MSL Solution Providers
  62. 8.11.1 MSL Solution Providers Company Information
  63. 8.11.2 MSL Solution Providers Business Overview
  64. 8.11.3 MSL Solution Providers Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MSL Solution Providers Antimicrobial Effectiveness Testing Service Product Portfolio
  66. 8.11.5 MSL Solution Providers Recent Developments
  67. 8.12 Consumer Product Testing Company
  68. 8.12.1 Consumer Product Testing Company Company Information
  69. 8.12.2 Consumer Product Testing Company Business Overview
  70. 8.12.3 Consumer Product Testing Company Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Consumer Product Testing Company Antimicrobial Effectiveness Testing Service Product Portfolio
  72. 8.12.5 Consumer Product Testing Company Recent Developments
  73. 8.13 QACS
  74. 8.13.1 QACS Company Information
  75. 8.13.2 QACS Business Overview
  76. 8.13.3 QACS Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 QACS Antimicrobial Effectiveness Testing Service Product Portfolio
  78. 8.13.5 QACS Recent Developments
  79. 8.14 Microchem Laboratory
  80. 8.14.1 Microchem Laboratory Company Information
  81. 8.14.2 Microchem Laboratory Business Overview
  82. 8.14.3 Microchem Laboratory Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Microchem Laboratory Antimicrobial Effectiveness Testing Service Product Portfolio
  84. 8.14.5 Microchem Laboratory Recent Developments
  85. 8.15 BioScreen
  86. 8.15.1 BioScreen Company Information
  87. 8.15.2 BioScreen Business Overview
  88. 8.15.3 BioScreen Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BioScreen Antimicrobial Effectiveness Testing Service Product Portfolio
  90. 8.15.5 BioScreen Recent Developments
  91. 8.16 Lucideon
  92. 8.16.1 Lucideon Company Information
  93. 8.16.2 Lucideon Business Overview
  94. 8.16.3 Lucideon Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Lucideon Antimicrobial Effectiveness Testing Service Product Portfolio
  96. 8.16.5 Lucideon Recent Developments
  97. 8.17 Microbac
  98. 8.17.1 Microbac Company Information
  99. 8.17.2 Microbac Business Overview
  100. 8.17.3 Microbac Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Microbac Antimicrobial Effectiveness Testing Service Product Portfolio
  102. 8.17.5 Microbac Recent Developments
  103. 8.18 Pace Life Sciences
  104. 8.18.1 Pace Life Sciences Company Information
  105. 8.18.2 Pace Life Sciences Business Overview
  106. 8.18.3 Pace Life Sciences Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Pace Life Sciences Antimicrobial Effectiveness Testing Service Product Portfolio
  108. 8.18.5 Pace Life Sciences Recent Developments
  109. 8.19 Neopharm
  110. 8.19.1 Neopharm Company Information
  111. 8.19.2 Neopharm Business Overview
  112. 8.19.3 Neopharm Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Neopharm Antimicrobial Effectiveness Testing Service Product Portfolio
  114. 8.19.5 Neopharm Recent Developments
  115. 8.20 Pacific BioLabs
  116. 8.20.1 Pacific BioLabs Company Information
  117. 8.20.2 Pacific BioLabs Business Overview
  118. 8.20.3 Pacific BioLabs Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Pacific BioLabs Antimicrobial Effectiveness Testing Service Product Portfolio
  120. 8.20.5 Pacific BioLabs Recent Developments
  121. 8.21 BA Sciences
  122. 8.21.1 BA Sciences Company Information
  123. 8.21.2 BA Sciences Business Overview
  124. 8.21.3 BA Sciences Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 BA Sciences Antimicrobial Effectiveness Testing Service Product Portfolio
  126. 8.21.5 BA Sciences Recent Developments
  127. 8.22 SGS S.A.
  128. 8.22.1 SGS S.A. Company Information
  129. 8.22.2 SGS S.A. Business Overview
  130. 8.22.3 SGS S.A. Antimicrobial Effectiveness Testing Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 SGS S.A. Antimicrobial Effectiveness Testing Service Product Portfolio
  132. 8.22.5 SGS S.A. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst